Author:
Mergental Hynek,Kriz Jan,Honsova Eva,Kudla Michal,Pantoflicek Tomas,Tcherentsova Katerina,Kocik Matej,Saudek Frantisek,Ryska Miroslav
Reference12 articles.
1. Kaye SB. Gemcitabine?Current status of phase I and II trials. J Clin Oncol 1994; 12:1527.
2. Lawrence TS, Eisbruch A, McGinn CJ, Fields MT, Shewach DS. Radiosensitization by gemcitabine. Oncology (Huntingt) 1999; 13 [Suppl 5]:55.
3. Margreiter R, Fischer M, Roberts K, Schmidt T, Hittmair A, Schirmer M, et al. Gemcitabine?a novel immunosuppressive agent?prevents rejection in a rat cardiac transplantation model. Transplantation 1999; 68:1051.
4. Jung F, Wilker S, Maas E, Berendel MD, Grimm H, Korom S. Gemcitabine in models of acute and accelerated rejection. Transplant Proc 2002; 34:1420.
5. Plunkett W, Huang P, Gandhi V. Preclinical characteristics of gemcitabine. Anticancer Drugs 1995; 6 [Suppl 6]:7.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献